OBJECTIVE to study the relative bioavailability of two kinds of Captopril tablets in human.
目的研究两种卡托普利片剂的人体相对生物利用度。
Results The problems of bad content uniformity and higher content of Captopril disulfide in Captopril Tablets were Solved.
结果卡托普利片含量均匀度合格，质量稳定。
Conclusion: Both captopril sustained-release tablets and valsartan are effective, and the combining use of the two drugs is effective on refractory hypertension in uremia patients.
结论：缬沙坦、卡托普利缓释片是治疗高血压的有效药物，二者联合应用是治疗尿毒症顽固性高血压的较好方法。
Conclusion: Both captopril sustained-release tablets and valsartan are effective, and the combining use of the two drugs is effective on refractory hypertension in uremia patients.
结论：缬沙坦、卡托普利缓释片是治疗高血压的有效药物，二者联合应用是治疗尿毒症顽固性高血压的较好方法。
应用推荐